Pharmazeutische Chemie

Dr. Tamer M. Ibrahim M. Abdelrehim

Visiting Scientist
Pharmacist

Lab for Molecular Design & Pharmaceutical Biophysics
Institute of Pharmaceutical Sciences
Eberhard Karls University Tuebingen
Auf der Morgenstelle 8 (Haus B)
72076 Tübingen, Germany
Phone 72476 (nur universitätsintern)
Fax +49-7071-29-5637
Email: tamer.abdelrehimspam prevention@pharm.uni-tuebingen.de

 

Publications

Name in Publications: Tamer M. Ibrahim 

  1. Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
    Ashraf H. Abadi, Tamer M. Ibrahim, Khaled M. Abouzid, Jochen Lehmann, Heather N. Tinsley, Bernard D. Gary, Gary A. Piazza.
    Bioorganic & Medicinal Chemistry 2009 Aug 15; 17(16):5974-82. DOI:10.1016/j.bmc.2009.06.063.
  2. Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0 – A Public Library of Challenging Docking Benchmark Sets
    Matthias R. Bauer, Tamer M. Ibrahim, Simon M. Vogel and Frank M. Boeckler. 
    Journal of Chemical Information and Modeling 2013 Jun 24; 53(6):1447-62. DOI: 10.1021/ci400115b.
  3. Applying DEKOIS 2.0 in Structure-Based Virtual Screening to Probe the Impact of Preparation Procedures and Score Normalization
    Tamer M. Ibrahim, Matthias R. Bauer and Frank M. Boeckler.
    Journal of Cheminformatics 2015 May 20; 7(21). DOI: 10.1186/s13321-015-0074-6.
  4. pROC-Chemotype Plots Enhance the Interpretability of Benchmarking Results in Structure-Based Virtual Screening
    Tamer M. Ibrahim, Matthias R. Bauer, Alexander Dörr and Frank M. Boeckler
    Journal of Chemical Information and Modeling 2015 Oct 5; 55 (11): 2297–2307. DOI: 10.1021/acs.jcim.5b00475.
  5. Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach
    Engi A. Hassaan, Sara C. Sigler, Tamer M. Ibrahim, Kevin J. Lee, Lauren K. Cichon, Bernard D. Gary, Joshua C. Canzoneri, Gary A. Piazza and Ashraf H Abadi.
    Medicinal Chemistry, 2016; 12 (5): 472-477. DOI: 10.2174/1573406412666151204002836.
  6. Synthesis, Evaluation and Modeling of Some Triazolothienopyrimidinones as Anti-inflammatory and Antimicrobial Agents
    Adnan A. Bekhit, Ahmed M. Farghaly, Ragab M. Shafik , Mona M. A. Elsemary, Alaa E. A. Bekhit, Mai S. El-Shoukrofy and Tamer M. Ibrahim
    Future Medicinal Chemistry 2017 June 21; 9(9): 881–897. DOI: 10.4155/fmc-2016-0242.
  7. Synthesis, Modeling and Biological Evaluation of Hybrids from Pyrazolo[1,5-c]Pyrimidine as Antileishmanial Agents
    Kamal F. M. Atta, Tamer M. Ibrahim, Omaima O. M. Farahat, Tareq Q. Al-Shargabi, Mohamed G. Marei, Adnan A. Bekhit and El Sayed H. El Ashry
    Future Medicinal Chemistry 2017 Oct. 13; 9(16): 1913–1929. DOI:10.4155/fmc-2017-0120.
  8. Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents
    Adnan A. Bekhit, Ahmed M. Farghaly, Ragab M. Shafik, Mona M. A. Elsemary, Alaa E. A. Bekhit, Aida A. Guemei, Mai S. El-Shoukrofy and Tamer M. Ibrahim
    Bioorganic Chemistry 2018 Jan 4; 77: 38-46. DOI: 10.1016/j.bioorg.2017.
  9. Synthesis, anti-Inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives
    Ibrahim Chaaban, Ola H. Rizk, Tamer M. Ibrahim, El-Sayeda M. El-Khawass, Shery S. Henen, Aida E. Bayad, Ibrahim M. El-Ashmawy, Hisham A. Nematalla
    Bioorganic Chemistry 2018 Mar 20; 78: 220-235. DOI: 10.1016/j.bioorg.2018.03.023.
  10. Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents
    Adnan A. Bekhit, Manal N. Saudi, Ahmed M. M. Hassan, Salwa M. Fahmy, Tamer M. Ibrahim, Doaa Ghareeb, Aya M. El-Seidy, Sayed M. Al-qallaf, Huda J. Habib, Alaa El-Din A. Bekhit
    Future Medicinal Chemistry 2018 Oct 1;10(19):2325-2344. DOI: 10.4155/fmc-2018-0058.
  11. Leishmania treatment and prevention: Natural and synthesized drugs
    Adnan A Bekhit, Eman El-Agroudy, Aliaa Helmy, Tamer M Ibrahim, Amin Shavandi, Alaa El-Din A Bekhit
    European Journal of Medicinal Chemistry 2018 Dec 5; 160: 229-244. DOI: 10.1016/j.ejmech.2018.10.022.
  12. Syntheses and in silico pharmacokinetic predictions of glycosylhydrazinyl-pyrazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]triazolo[4,3-a]pyrimidines as anti-proliferative agents
    Kamal FM Atta, Omaima OM Farahat, Tareq Q Al-Shargabi, Mohamed G Marei, Tamer M Ibrahim, Adnan A Bekhit, El Sayed H. El Ashry
    Medicinal Chemistry Research 2019 Feb; 28, 2, 215–227. DOI: https://doi.org/10.1007/s00044-018-2277-7.
  13. Green synthesis, antileishmanial activity evaluation, and in silico studies of new amino acid-coupled 1,2,4-triazoles
    Ahmed M. El-Saghier, Mounier A. Mohamed, Omyma A. Abd-Allah, Asmaa M. Kadry, Tamer M. Ibrahim, Adnan A. Bekhit
    Medicinal Chemistry Research 2019 Feb; 28, 2, 169–181. DOI: https://doi.org/10.1007/s00044-018-2274-x.
  14. Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents.
    Adnan A. Bekhit, Manal N. Saudi, Ahmed M. M. Hassan, Salwa M. Fahmy, Tamer M. Ibrahim, Aya M. El-Seidy and Alaa El-Din A. Bekhit 
    European Journal of Medicinal Chemistry 2019 Feb 1; 163: 353-366. DOI: 10.1016/j.ejmech.2018.11.067.
  15. Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones
    Perihan A Elzahhar, Rana Alaaeddine, Tamer M Ibrahim, Rasha Nassra, Azza Ismail, Benjamin SK Chua, Rebecca L Frkic, John B Bruning, Nadja Wallner, Tilo Knape, Andreas von Knethen, Hala Labib, Ahmed F El-Yazbi, Ahmed SF Belal
    European Journal of Medicinal Chemistry 2019 Feb 13; 167: 562-582. DOI: 10.1016/j.ejmech.2019.02.034.
  16. Synthesis, Modeling and Biological Evaluation of Some Pyrazolo[3,4-d]pyrimidinones and Pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as Anti-inflammatory Agents
    Gina N. Tageldin, Tamer M. Ibrahim, Salwa M. Fahmy, Hayam M. Ashour, Mounir A. Khalil, Rasha A. Nassra, Ibrahim M. Labouta.
    Bioorganic Chemistry 2019, in press. DOI: 10.1016/j.bioorg.2019.03.018.